Metropolitan Life Insurance Company (MetLife)’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,318
| Closed | -$52.2K | – | 2394 |
|
|
2022
Q2 | $52.2K | Hold |
3,318
| – | – | ﹤0.01% | 1482 |
|
|
2022
Q1 | $50.5K | Sell |
3,318
-9,178
| -73% | -$140K | ﹤0.01% | 1584 |
|
|
2021
Q4 | $192K | Buy |
12,496
+691
| +6% | +$9.09K | ﹤0.01% | 2053 |
|
|
2021
Q3 | $103K | Hold |
11,805
| – | – | ﹤0.01% | 2503 |
|
|
2021
Q2 | $121K | Buy |
11,805
+1,076
| +10% | +$11.4K | ﹤0.01% | 2500 |
|
|
2021
Q1 | $128K | Sell |
10,729
-1,222
| -10% | -$13.9K | ﹤0.01% | 2313 |
|
|
2020
Q4 | $109K | Hold |
11,951
| – | – | ﹤0.01% | 2320 |
|
|
2020
Q3 | $72.8K | Sell |
11,951
-7,328
| -38% | -$55.9K | ﹤0.01% | 2386 |
|
|
2020
Q2 | $171K | Buy |
19,279
+6,765
| +54% | +$58.3K | ﹤0.01% | 1906 |
|
|
2020
Q1 | $90.7K | Sell |
12,514
-281
| -2% | -$2.08K | ﹤0.01% | 2089 |
|
|
2019
Q4 | $113K | Sell |
12,795
-277
| -2% | -$2.07K | ﹤0.01% | 2262 |
|
|
2019
Q3 | $79.6K | Buy |
13,072
+810
| +7% | +$4.55K | ﹤0.01% | 2424 |
|
|
2019
Q2 | $51.3K | Hold |
12,262
| – | – | ﹤0.01% | 2504 |
|
|
2019
Q1 | $77.1K | Sell |
12,262
-57
| -0.5% | -$399 | ﹤0.01% | 2455 |
|
|
2018
Q4 | $79.8K | Hold |
12,319
| – | – | ﹤0.01% | 2414 |
|
|
2018
Q3 | $102K | Buy |
+12,319
| New | +$93.7K | ﹤0.01% | 2443 |
|
|
2017
Q3 | – | Sell |
-21,562
| Closed | -$166K | – | 2548 |
|
|
2017
Q2 | $166K | Hold |
21,562
| – | – | ﹤0.01% | 2445 |
|
|
2017
Q1 | $194K | Hold |
21,562
| – | – | ﹤0.01% | 2287 |
|
|
2016
Q4 | $233K | Hold |
21,562
| – | – | ﹤0.01% | 2255 |
|
|
2016
Q3 | $352K | Hold |
21,562
| – | – | ﹤0.01% | 1950 |
|
|
2016
Q2 | $205K | Hold |
21,562
| – | – | ﹤0.01% | 2307 |
|
|
2016
Q1 | $303K | Hold |
21,562
| – | – | ﹤0.01% | 1896 |
|
|
2015
Q4 | $234K | Buy |
21,562
+489
| +2% | +$4.42K | ﹤0.01% | 2145 |
|
|
2015
Q3 | $144K | Sell |
21,073
-22
| -0.1% | -$170 | ﹤0.01% | 2496 |
|
|
2015
Q2 | $193K | Buy |
+21,095
| New | +$160K | ﹤0.01% | 2430 |
|
|
2013
Q3 | – | Sell |
-18,030
| Closed | -$157K | – | 2778 |
|
|
2013
Q2 | $157K | Buy |
+18,030
| New | +$116K | ﹤0.01% | 2519 |
|
Other funds holding NPTN
Metropolitan Life Insurance Company (MetLife)'s NPTN Position: Q3 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 3,318 shares — an estimated $52.2K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NPTN in Q2 2013 and held it in 26 quarters. The position peaked at $352K in Q3 2016. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,318 NEOPHOTONICS CORP shares in Q3 2022, an estimated $52.2K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 26 quarters.
- Metropolitan Life Insurance Company (MetLife)'s NEOPHOTONICS CORP position peaked at $352K in Q3 2016.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.